Evaluation of Panobinostat (LBH589) as Maintenance Therapy in Multiple Myeloma Following Autologous Hematopoietic Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Panobinostat (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 10 Jun 2016 Status changed from not yet recruiting to recruiting.
- 25 Apr 2016 Planned initiation date changed from 1 May 2016 to 1 Jul 2016.
- 02 Apr 2016 New trial record